StockData
OrthoPediatrics Corp logo

OrthoPediatrics Corp (KIDS) stock

KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/308% below fair value
$31.41−0.09 (-0.29%)

Close on Nov 17, 2026Market cap $820.13MP/E –Yield –

OrthoPediatrics Corp grew revenue 16.1% to $264.14M over the twelve months to Sep 30, 2026. Free cash flow was $3.18M. At the latest close the market valued the company at $820.13M.

Revenue
$264.14M
+16.1% vs. a year earlier
Operating income
-$24.80M
TTM Q3 2026
Free cash flow
$3.18M
TTM Q3 2026
EPS, diluted
-$1.43
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$820.13M
P/E ratio
–
Price to sales
3.10
Price to book
2.42
Dividend yield
–
Free cash flow yield
0.39%

Fundamentals

Revenue
$264.14M
Net income
-$33.88M
EPS, diluted
-$1.43
Free cash flow
$3.18M
Book value per share
$14.05
Diluted shares
24M

Trading

Next earnings
Feb 25, 2027 (estimated, during market hours)
Previous close
$31.50
Open
$31.34
Day's range
$30.99 – $32.04
Volume
172,044
Average volume (20 days)
442,239
Index membership
Russell 2000, Russell 3000
52-week range
$14.42 – $34.53
RSI (14 days)
60.4
Volatility (1 year)
52.2%
Relative volume
0.66×

Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2017, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.

PeriodKIDSS&P 500DifferenceKIDS per yearS&P 500 per year
1 month+43.1%-4.0%+47.1 pts
3 months+27.2%-5.0%+32.1 pts
Year to date+76.9%+8.2%+68.6 pts
1 year+92.5%+11.2%+81.2 pts
3 years+0.6%+68.5%−67.8 pts+0.2%+19.0%
5 years-51.3%+67.3%−118.6 pts-13.4%+10.8%
10 years+62720.0%+291.6%+62428.4 pts+90.5%+14.6%

Twelve years at a glance

Fiscal years 2014 to 2025 and trailing twelve months, USD

Revenue

$264.14M+16.1% YoY

Gross profit

$194.84M+19.4% YoY

Operating income

-$24.80M

Net income

-$33.88M

EPS, diluted

-$1.43

Free cash flow

$3.18M
Reported periodTrailing twelve months

Press releases

Releases OrthoPediatrics filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About OrthoPediatrics

Surgical & Medical Instruments & Apparatus

OrthoPediatrics Corp. is a medical device company that develops, manufactures, and markets anatomically appropriate implants, surgical instruments, and specialized bracing products for children with orthopedic conditions. The company also provides non-surgical clinical care through a network of orthotic and prosthetic clinics. Its offerings address three primary categories: trauma and deformity correction, scoliosis, and sports medicine. OrthoPediatrics designs its systems to accommodate pediatric anatomy and protect children's growth plates, serving pediatric orthopedic surgeons, caregivers, and pediatric hospitals.

Company profile, executives and history

OrthoPediatrics stock: common questions

What is OrthoPediatrics's stock price?

KIDS closed at $31.41 on Nov 17, 2026, down 0.29% on the day. Over the past 52 weeks it traded between $14.42 and $34.53.

What is OrthoPediatrics's market cap?

OrthoPediatrics was worth $820.13M at the close on Nov 17, 2026: the share price times the diluted shares outstanding.

What is KIDS's P/E ratio?

OrthoPediatrics lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.43), so it has no meaningful P/E ratio.

How much revenue does OrthoPediatrics make?

OrthoPediatrics reported revenue of $264.14M for the twelve months to Sep 30, 2026, up 16.1% from a year earlier.

Does OrthoPediatrics pay a dividend?

No. OrthoPediatrics has not paid a cash dividend over the last twelve months.

When does OrthoPediatrics report earnings next?

OrthoPediatrics is expected to report Q4 FY2026 results on Feb 25, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has KIDS stock performed over the past year?

Including dividends, KIDS returned +92.5% over the past year, against +11.2% for the S&P 500.

How many KIDS shares are sold short?

1M shares were sold short at the latest FINRA report, 4.12% of the float, or 1.5 days of average trading volume.

Who are OrthoPediatrics's competitors?

Companies most similar to OrthoPediatrics by business, industry and size include SIBN, LMAT, BVS, OFIX, XTNT.

See a number that looks wrong?